Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
22/09/2026 14:22
BRIEF-Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement Sept 22 (Reuters) - Lunai Bioworks Inc LNAI.O:
LUNAI BIOWORKS (NASDAQ: LNAI) EXPANDS PARKINSON'S PLATFORM THROUGH EXCLUSIVE TANAIST AGREEMENT
LUNAI BIOWORKS - RECEIVES EXCLUSIVE RIGHTS TO TANAIST CELLULAR PHENOTYPING TECHNOLOGY FOR PARKINSON'S
LUNAI BIOWORKS - TO OWN COLLABORATION-GENERATED RESULTS AND INTELLECTUAL PROPERTY
Source text: ID:nPn5bHq6na
Further company coverage: LNAI.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing